Prodromal frontotemporal dementia: clinical features and predictors of progression
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-9193
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Prodromal frontotemporal dementia: clinical features and predictors of progression ; volume:13 ; number:1 ; day:15 ; month:11 ; year:2021 ; pages:1-10 ; date:12.2021
Alzheimer's research & therapy ; 13, Heft 1 (15.11.2021), 1-10, 12.2021
- Creator
-
Benussi, Alberto
Ashton, Nicholas J.
Karikari, Thomas K.
Alberici, Antonella
Saraceno, Claudia
Ghidoni, Roberta
Benussi, Luisa
Zetterberg, Henrik
Blennow, Kaj
Borroni, Barbara
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13195-021-00932-2
- URN
-
urn:nbn:de:101:1-2022012522062028585208
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Benussi, Alberto
- Ashton, Nicholas J.
- Karikari, Thomas K.
- Alberici, Antonella
- Saraceno, Claudia
- Ghidoni, Roberta
- Benussi, Luisa
- Zetterberg, Henrik
- Blennow, Kaj
- Borroni, Barbara
- SpringerLink (Online service)
Other Objects (12)
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Sex influences clinical phenotype in frontotemporal dementia
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer’s disease
Chemometric Strategies for Sensitive Annotation and Validation of Anatomical Regions of Interest in Complex Imaging Mass Spectrometry Data
Repeated lumbar punctures within 3 days may affect CSF biomarker levels
BACE1gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease
Cognitive impairment without altered levels of cerebrospinal fluid biomarkers in patients with encephalitis caused by varicella-zoster virus: a pilot study
Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus
Low plasma neurofilament light levels associated with raised cortical microglial activation suggest inflammation acts to protect prodromal Alzheimer’s disease
Analytical and clinical validation of a blood progranulin ELISA in frontotemporal dementias
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Sex influences clinical phenotype in frontotemporal dementia
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer’s disease
Chemometric Strategies for Sensitive Annotation and Validation of Anatomical Regions of Interest in Complex Imaging Mass Spectrometry Data
Repeated lumbar punctures within 3 days may affect CSF biomarker levels
BACE1gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease
Cognitive impairment without altered levels of cerebrospinal fluid biomarkers in patients with encephalitis caused by varicella-zoster virus: a pilot study
Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus
Low plasma neurofilament light levels associated with raised cortical microglial activation suggest inflammation acts to protect prodromal Alzheimer’s disease
Analytical and clinical validation of a blood progranulin ELISA in frontotemporal dementias
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Sex influences clinical phenotype in frontotemporal dementia
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer’s disease
Chemometric Strategies for Sensitive Annotation and Validation of Anatomical Regions of Interest in Complex Imaging Mass Spectrometry Data
Repeated lumbar punctures within 3 days may affect CSF biomarker levels
BACE1gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease
Cognitive impairment without altered levels of cerebrospinal fluid biomarkers in patients with encephalitis caused by varicella-zoster virus: a pilot study
Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus
Low plasma neurofilament light levels associated with raised cortical microglial activation suggest inflammation acts to protect prodromal Alzheimer’s disease